Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
Condition:   Lymphatic Filariasis Interventions:   Drug: 3 drug dose - IDA;   Drug: 2 drug dose - DA Sponsors:   Washington University School of Medicine;   Case Western Reserve University;   Indian Council of Medical Research Active, not recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2016 Category: Research Source Type: clinical trials

Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
Condition:   Lymphatic Filariasis Intervention:   Drug: 3 drug dose - IDA Sponsors:   Washington University School of Medicine;   Case Western Reserve University;   Indian Council of Medical Research Active, not recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2016 Category: Research Source Type: clinical trials

Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
Condition:   Lymphatic Filariasis Interventions:   Drug: 3 drug dose - IDA;   Drug: 2 drug dose - DA Sponsors:   Washington University School of Medicine;   Case Western Reserve University;   Indian Council of Medical Research Active, not recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2016 Category: Research Source Type: clinical trials

Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
Condition:   Lymphatic Filariasis Intervention:   Drug: 3 drug dose - IDA Sponsors:   Washington University School of Medicine;   Case Western Reserve University;   Indian Council of Medical Research Active, not recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2016 Category: Research Source Type: clinical trials

Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
Condition:   Lymphatic Filariasis Interventions:   Drug: 3 drug dose - IDA;   Drug: 2 drug dose - DA Sponsors:   Washington University School of Medicine;   Case Western Reserve University;   Indian Council of Medical Research Active, not recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2016 Category: Research Source Type: clinical trials

Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNG
Condition:   Lymphatic Filariasis Intervention:   Sponsors:   University Hospitals Cleveland Medical Center;   Papua New Guinea Institute of Medical Research Recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2013 Category: Research Source Type: clinical trials